Ellen O'Connor Vos - 04 Jun 2025 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)

Reporting relationship: Director
Issuer ticker: AWHL
Reported as of: 04 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2025, 16:05:21 UTC
Prior SEC filing: 02 Apr 2025
Next SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Ellen O'Connor Vos

Key filing fact

Ellen O'Connor Vos filed Form 4 for Aspira Women's Health Inc. (AWHL) on 06 Jun 2025.

Key facts

This page summarizes Ellen O'Connor Vos's Form 4 filing for Aspira Women's Health Inc. (AWHL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2025, 16:05.

Change

Previous filing in this sequence was filed on 02 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001534357 Primary reporting owner

Vos Ellen O'Connor

Relationship: Director
Address: C/O ASPIRA WOMEN'S HEALTH INC, 12117 BEE CAVES RD, BLDG 3-100, AUSTIN,
Signature: /s/ Ellen O'Connor Vos
Signature date: 06 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AWHL transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +5,312
Change %: +7.7%
Price: $0.000000
Shares after: 73,989
Date: 04 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AWHL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -5,312
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 04 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,312
Exercise price
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ellen O'Connor Vos is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.

Footnote F2

Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.

Footnote F3

On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.